{"id":762429,"date":"2025-09-10T18:28:01","date_gmt":"2025-09-10T18:28:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=762429"},"modified":"2025-09-10T18:28:01","modified_gmt":"2025-09-10T18:28:01","slug":"hyperopia-market-overview-epidemiology-emerging-therapies-and-key-players-featuring-nevakar-zeimer-ophthalmic-systems-ag-carl-zeiss-meditec-ag-abbvie-sydnexis-alcon-inc-bausch-health-compa","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/hyperopia-market-overview-epidemiology-emerging-therapies-and-key-players-featuring-nevakar-zeimer-ophthalmic-systems-ag-carl-zeiss-meditec-ag-abbvie-sydnexis-alcon-inc-bausch-health-compa_762429.html","title":{"rendered":"Hyperopia Market Overview: Epidemiology, Emerging Therapies, and Key Players | Featuring Nevakar, Zeimer Ophthalmic Systems AG, Carl Zeiss Meditec AG, AbbVie, Sydnexis, ALCON Inc., Bausch Health Compa"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/upload\/2025\/09\/1757476380.jpg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Hyperopia Market Overview: Epidemiology, Emerging Therapies, and Key Players | Featuring Nevakar, Zeimer Ophthalmic Systems AG, Carl Zeiss Meditec AG, AbbVie, Sydnexis, ALCON Inc., Bausch Health Compa\" src=\"https:\/\/www.abnewswire.com\/upload\/2025\/09\/1757476380.jpg\" alt=\"Hyperopia Market Overview: Epidemiology, Emerging Therapies, and Key Players | Featuring Nevakar, Zeimer Ophthalmic Systems AG, Carl Zeiss Meditec AG, AbbVie, Sydnexis, ALCON Inc., Bausch Health Compa\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Hyperopia Market<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">The Hyperopia market report provides current treatment practices, emerging drugs, Hyperopia market share of individual therapies, and current and forecasted Hyperopia market size from 2020 to 2034, segmented by seven major markets. The report also covers current Hyperopia treatment practices\/algorithms and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.<\/div>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">Emerging therapies for Hyperopia, including NVK-033 and others, are anticipated to drive growth in the Hyperopia market over the coming years.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">DelveInsight has released a new report titled &ldquo;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/hyperopia-market?utm_source=abnewswire&amp;utm_medium=market&amp;utm_campaign=kpr\">Hyperopia Market Insights, Epidemiology, and Market Forecast 2034<\/a>&rdquo;, offering comprehensive insights into Hyperopia, along with historical and projected epidemiology and market trends across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Explore more about Hyperopia market report 2034 @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/hyperopia-market?utm_source=abnewswire&amp;utm_medium=market&amp;utm_campaign=kpr\">https:\/\/www.delveinsight.com\/report-store\/hyperopia-market?utm_source=abnewswire&amp;utm_medium=market&amp;utm_campaign=kpr<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some of the key facts of the Hyperopia Market Report:<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>In 2023, the total Hyperopia market size across the 7MM was estimated at around USD 3.2 billion, with the current treatment landscape largely dominated by corrective lenses and surgical procedures.<\/p>\n<\/li>\n<li>\n<p>The market remains relatively underdeveloped, as no pharmacological therapies have yet been approved. However, Vyluma&rsquo;s NVK-033, currently in the clinical proof-of-principle stage, holds promise as a potential first-in-class drug for Hyperopia.<\/p>\n<\/li>\n<li>\n<p>In the United States, the highest prevalence of Hyperopia was noted in individuals aged 60&ndash;69 years, accounting for nearly 25% of reported cases.<\/p>\n<\/li>\n<li>\n<p>In January 2025, ZEISS Medical Technology received FDA approval for the MEL&reg; 90 excimer laser to treat myopia, hyperopia, and mixed astigmatism. Designed to integrate with the Corneal Refractive Workflow, the MEL 90 provides surgeons with a fast, efficient, and reliable surgical solution, complementing the VISUMAX&reg; 800 with SMILE&reg; pro to further advance refractive care and improve patient outcomes.<\/p>\n<\/li>\n<li>\n<p>Key Hyperopia players such as Nevakar, Zeimer Ophthalmic Systems AG, Carl Zeiss Meditec AG, AbbVie, Sydnexis, ALCON Inc., Bausch Health Companies Inc., Johnson &amp; Johnson Vision, NIDEK CO. LTD, Topcon Corporation, Essilor Luxottica (Essilor Ltd), Regeneron Pharmaceuticals Inc., Orasis Pharmaceuticals, The Cooper Companies Inc., and others are actively evaluating new therapies to transform the treatment landscape.<\/p>\n<\/li>\n<li>\n<p>Promising pipeline therapies include NVK-033 and additional candidates in development.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Key benefits of the Hyperopia market report:<\/strong><\/p>\n<ol style=\"text-align: justify;\">\n<li>\n<p>Hyperopia market report covers a descriptive overview and comprehensive insight of the Hyperopia Epidemiology and Hyperopia market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) &amp; Japan.)<\/p>\n<\/li>\n<li>\n<p>The Hyperopia market report provides insights on the current and emerging therapies.<\/p>\n<\/li>\n<li>\n<p>Hyperopia market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/p>\n<\/li>\n<li>\n<p>The Hyperopia market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Hyperopia market.<\/p>\n<\/li>\n<\/ol>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Got queries? Click here to know more about the Hyperopia Market Landscape @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/hyperopia-market?utm_source=abnewswire&amp;utm_medium=market&amp;utm_campaign=kpr\">https:\/\/www.delveinsight.com\/sample-request\/hyperopia-market?utm_source=abnewswire&amp;utm_medium=market&amp;utm_campaign=kpr<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Hyperopia Overview<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">Hyperopia, commonly known as farsightedness, is a refractive error of the eye in which distant objects are seen more clearly than near ones. It occurs when light entering the eye focuses behind the retina instead of directly on it, usually due to a shorter-than-normal eyeball or an abnormally flat cornea.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Hyperopia Market Outlook<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">Hyperopia, also known as farsightedness, is a refractive condition in which distant vision is clearer than near vision. It can occur across all age groups and often impacts daily tasks such as reading or digital device use. The increasing prevalence of hyperopia continues to fuel market growth. Treatment needs vary with severity&mdash;mild to moderate cases are usually corrected with eyeglasses or contact lenses. In 2018, the US FDA approved Acuvue Oasys Contact Lenses, the first lenses designed to automatically darken under bright light. For patients who do not achieve sufficient improvement with lenses, surgical interventions such as LASIK or Refractive Lens Exchange (RLE) are available to enhance focusing ability. Additional procedures, including LASEK, PRK, and Conductive Keratoplasty, offer alternatives but require detailed counseling to weigh their risks and benefits.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Discover how the Hyperopia market is growing in the coming years @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/hyperopia-market?utm_source=abnewswire&amp;utm_medium=market&amp;utm_campaign=kpr\">https:\/\/www.delveinsight.com\/report-store\/hyperopia-market?utm_source=abnewswire&amp;utm_medium=market&amp;utm_campaign=kpr<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Hyperopia Emerging Therapy Assessment<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>NVK-033: Vyluma<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Scope of the Hyperopia Market Report<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Study Period: 2020-2034<\/p>\n<\/li>\n<li>\n<p>Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]<\/p>\n<\/li>\n<li>\n<p>Key Hyperopia Companies: Nevakar, Zeimer Ophthalmic Systems AG, Carl Zeiss Meditec AG, AbbVie, Sydnexis, ALCON Inc., Bausch Health Companies Inc., Johnson &amp; Johnson Vision, NIDEK CO. LTD, Topcon Corporation, Essilor Luxottica (Essilor Ltd), Regeneron Pharmaceuticals Inc., Orasis Pharmaceuticals, The Cooper Companies Inc., and others<\/p>\n<\/li>\n<li>\n<p>Key Hyperopia Therapies: NVK-033, and others<\/p>\n<\/li>\n<li>\n<p>Hyperopia Therapeutic Assessment: Hyperopia current marketed and Hyperopia emerging therapies<\/p>\n<\/li>\n<li>\n<p>Hyperopia Market Dynamics: Hyperopia market drivers and Hyperopia market barriers<\/p>\n<\/li>\n<li>\n<p>Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter&#8217;s five forces, BCG Matrix, Market entry strategies<\/p>\n<\/li>\n<li>\n<p>Hyperopia Unmet Needs, KOL&#8217;s views, Analyst&#8217;s views, Hyperopia Market Access and Reimbursement<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">1. Report Introduction<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary<\/p>\n<p style=\"text-align: justify;\">3. SWOT analysis<\/p>\n<p style=\"text-align: justify;\">4. Hyperopia Patient Share (%) Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Hyperopia Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">6. Hyperopia Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">7. Hyperopia Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Country-Specific Patient Population of Hyperopia<\/p>\n<p style=\"text-align: justify;\">9. Hyperopia Current Treatment and Medical Practices<\/p>\n<p style=\"text-align: justify;\">10. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">11. Hyperopia Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">12. Hyperopia Market Outlook<\/p>\n<p style=\"text-align: justify;\">13. Country-Wise Hyperopia Market Analysis (2020&ndash;2034)<\/p>\n<p style=\"text-align: justify;\">14. Market Access and Reimbursement of Therapies<\/p>\n<p style=\"text-align: justify;\">15. Market drivers<\/p>\n<p style=\"text-align: justify;\">16. Market barriers<\/p>\n<p style=\"text-align: justify;\">17. Appendix<\/p>\n<p style=\"text-align: justify;\">18. Hyperopia Report Methodology<\/p>\n<p style=\"text-align: justify;\">19. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">20. Disclaimer<\/p>\n<p style=\"text-align: justify;\">21. About DelveInsight<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Click here to read more about <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/hyperopia-market?utm_source=abnewswire&amp;utm_medium=market&amp;utm_campaign=kpr\">Hyperopia Market Outlook 2034<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Hyperopia Pipeline Insights, DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\">&#8220;Hyperopia Pipeline Insight, 2024&#8221; report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Hyperopia market. A detailed picture of the Hyperopia pipeline landscape is provided, which includes the disease overview and Hyperopia treatment guidelines.<\/p>\n<p style=\"text-align: justify;\"><strong>About DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56431.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Kritika Rehani<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=hyperopia-market-overview-epidemiology-emerging-therapies-and-key-players-featuring-nevakar-zeimer-ophthalmic-systems-ag-carl-zeiss-meditec-ag-abbvie-sydnexis-alcon-inc-bausch-health-compa\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +14699457679<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=hyperopia-market-overview-epidemiology-emerging-therapies-and-key-players-featuring-nevakar-zeimer-ophthalmic-systems-ag-carl-zeiss-meditec-ag-abbvie-sydnexis-alcon-inc-bausch-health-compa\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hyperopia Market The Hyperopia market report provides current treatment practices, emerging drugs, Hyperopia market share of individual therapies, and current and forecasted Hyperopia market size from 2020 to 2034, segmented by seven major markets. The report also covers current Hyperopia &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/hyperopia-market-overview-epidemiology-emerging-therapies-and-key-players-featuring-nevakar-zeimer-ophthalmic-systems-ag-carl-zeiss-meditec-ag-abbvie-sydnexis-alcon-inc-bausch-health-compa_762429.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[435,405,406,403,404],"tags":[],"class_list":["post-762429","post","type-post","status-publish","format-standard","hentry","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/762429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=762429"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/762429\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=762429"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=762429"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=762429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}